Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Melanoma 4Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Tumor 1Skin Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Inflammatory Breast Neoplasms 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Craniopharyngioma 1Cholangiocarcinoma 1Carcinosarcoma 1Brain Neoplasms 1

Interventions

Radiosurgery 23Temozolomide 9Radiotherapy 8pembrolizumab 6Cyclophosphamide 6abemaciclib 5Nivolumab 5Radiation 4Mental Status and Dementia Tests 4Bevacizumab 4trastuzumab deruxtecan 3trametinib 3pertuzumab 3osimertinib 3entrectinib 3Surveys and Questionnaires 3Proton Therapy 3Magnetic Resonance Spectroscopy 3Lomustine 3Ipilimumab 3Immunoglobulin G 3Disulfides 3Cisplatin 3tucatinib 2encorafenib 2binimetinib 2Vincristine 2Trastuzumab 2Surgical Procedures, Operative 2Spermine Synthase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Brain Neoplasms × cobimetinib × Clear all
NCT03175432 2026-04-15

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
29 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡